
Cohance Lifesciences Limited — Investor Relations & Filings
Cohance Lifesciences Limited is a global platform specializing in Contract Development and Manufacturing Organization (CDMO) services and Active Pharmaceutical Ingredients (API). The organization provides end-to-end solutions ranging from process research and development to commercial-scale manufacturing. Its core competencies include complex chemistry, niche APIs, and specialty chemical intermediates. The company serves a global clientele across various therapeutic segments, maintaining a focus on regulatory compliance and quality standards. By leveraging integrated technical capabilities and a robust supply chain, Cohance Lifesciences delivers value-added services supporting the development and production of healthcare solutions. The platform is built upon the integration of multiple specialized entities to offer a diversified portfolio and scaled manufacturing infrastructure.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Investors Meet | 2026-05-25 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-25 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-15 | English | |
| Earnings Call Transcript | 2026-05-15 | English | |
| Copy of Newspaper Publication | 2026-05-15 | English | |
| Newspaper Publication | 2026-05-15 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47019540 | Investors Meet | 2026-05-25 | English | ||
| 47019637 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-25 | English | ||
| 46359515 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-15 | English | ||
| 46357699 | Earnings Call Transcript | 2026-05-15 | English | ||
| 46355595 | Copy of Newspaper Publication | 2026-05-15 | English | ||
| 46355794 | Newspaper Publication | 2026-05-15 | English | ||
| 46014642 | Shareholders meeting | 2026-05-14 | English | ||
| 46014841 | Notice of Postal Ballot | 2026-05-14 | English | ||
| 45642900 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-13 | English | ||
| 45641847 | Investors Meet | 2026-05-13 | English | ||
| 45469367 | Newspaper Publication | 2026-05-13 | English | ||
| 45469097 | Copy of Newspaper Publication | 2026-05-13 | English | ||
| 45329831 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | ||
| 45329710 | Audio of Conference Call | 2026-05-12 | English | ||
| 45271443 | Investor Presentation | 2026-05-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cohance Lifesciences Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59202/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59202 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59202 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59202 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59202}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cohance Lifesciences Limited (id: 59202)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.